AHA PREVENT Cardiovascular Risk Calculator

What Is the PREVENT ASCVD Risk Calculator?

The PREVENT risk calculator is a cardiovascular risk prediction model developed by the American Heart Association and published in Circulation in 2024 (Khan SS et al.). It estimates an individual's 10-year risk of major cardiovascular events, including myocardial infarction, stroke, and heart failure.

The 2026 ACC/AHA Guideline on the Management of Dyslipidemia recommends the PREVENT-ASCVD equations as the preferred tool for estimating 10-year cardiovascular risk in adults aged 30–79 years, replacing the older Pooled Cohort Equations used in previous guidelines.

Unlike the traditional ASCVD calculator, the PREVENT model estimates risk of both atherosclerotic cardiovascular disease and heart failure, reflecting the broader cardiovascular disease spectrum recognised in modern cardiometabolic risk assessment.

The PREVENT equations were derived from pooled data from more than six million adults across contemporary US cohorts, providing improved calibration and accuracy compared with earlier risk prediction models.

How the PREVENT Risk Calculator Differs From Traditional ASCVD Calculators

The PREVENT equations were designed to address several limitations of the traditional Pooled Cohort Equations (PCE) used in earlier ASCVD risk calculators.

Key differences include:

• Race-neutral design, removing race as a predictor variable
• Kidney function (eGFR) incorporated as a core risk factor
• Body mass index (BMI) included to capture metabolic risk
• Optional enhancement using HbA1c and urine albumin-creatinine ratio when available
• Broader age range (30–79 years) compared with 40–79 years in the traditional ASCVD calculator
• Inclusion of heart failure as an outcome, in addition to myocardial infarction and stroke
• Improved calibration to contemporary cardiovascular event rates

Because cardiovascular event rates have declined substantially over the past two decades due to improvements in prevention and treatment, the older PCE equations tended to overestimate cardiovascular risk in modern populations.

The PREVENT equations were recalibrated using contemporary cohort data. As a result, for the same patient risk profile, PREVENT often produces lower numerical risk estimates than the older PCE calculator.

Importantly, this does not mean the patient is at lower true risk. Instead, the PREVENT model more accurately reflects current real-world cardiovascular event rates, leading to more precise and better-calibrated risk estimates.

2026 Risk Categories (PREVENT-ASCVD)

Because PREVENT produces lower numerical risk estimates than the older PCE model, the risk thresholds used for treatment decisions are also lower.

The 2026 ACC/AHA dyslipidemia guideline defines the following PREVENT-based risk categories:

• Low risk: <3% — Lifestyle counselling recommended.
• Borderline risk: 3% to <5% — Moderate-intensity statin may be reasonable after clinician–patient discussion.
• Intermediate risk: 5% to <10% — At least moderate-intensity statin recommended; high-intensity statin may be considered toward the higher end of this range.
• High risk: ≥10% — High-intensity statin recommended to achieve ≥50% LDL-C reduction.

Although these percentages are lower than the traditional PCE thresholds (5%, 7.5%, and 20%), they generally identify similar patient groups for treatment, because the PREVENT model corrects the systematic overestimation of risk seen with the older equations.

The guideline emphasises a stepwise approach to risk assessment:

• Calculate risk using the PREVENT equations
• Personalise risk using risk-enhancing factors
• Reclassify risk with selective coronary artery calcium (CAC) testing when uncertainty remains

Role of Kidney and Metabolic Risk Factors

Kidney function and metabolic health are increasingly recognised as major determinants of cardiovascular risk.

Reduced estimated glomerular filtration rate (eGFR) and albuminuria are independent predictors of cardiovascular events. Cardiovascular risk increases progressively as kidney function declines, particularly once eGFR falls below 60 mL/min/1.73 m².

Similarly, body mass index (BMI) captures aspects of metabolic risk that are not fully reflected by cholesterol and blood pressure alone. For patients with diabetes, HbA1c provides additional prognostic information and allows more precise risk stratification within the diabetic population.

These factors reflect the broader concept of Cardiovascular-Kidney-Metabolic (CKM) syndrome, which recognises the close pathophysiological links between:

• Cardiovascular disease
• Chronic kidney disease
• Diabetes
• Obesity

The PREVENT equations incorporate several elements of the CKM framework by integrating cardiovascular, kidney, and metabolic risk factors into a single prediction model.

As a result, the PREVENT calculator may be particularly useful in patients with diabetes, chronic kidney disease, obesity, or metabolic syndrome, where traditional ASCVD calculators may not fully capture cardiovascular risk.

When the PREVENT Calculator Is Most Helpful

The PREVENT model is now the guideline-preferred tool for primary prevention risk estimation in adults aged 30–79 years.

It may be particularly helpful when assessing cardiovascular risk in:

• Patients with diabetes or prediabetes
• Patients with chronic kidney disease
• Individuals with metabolic syndrome or obesity
• Younger adults (ages 30–40) who fall outside the traditional ASCVD calculator range

For patients where coronary artery calcium (CAC) data is available, the MESA CAC calculator may provide additional risk refinement by incorporating direct imaging evidence of coronary atherosclerosis.